BUENA, N.J.--(BUSINESS WIRE)--IGI Laboratories, Inc. (NYSE AMEX: IG), a premier provider of topical formulation development, analytical, manufacturing and packaging services, today announced that NYSE Amex has determined that IGI has resolved its continued listing deficiencies and will retain its status as a listed issuer on NYSE Amex.
